Researchers at UT Southwestern have determined that "a new nanoparticle-based drug can boost the body's innate immune system and make it more effective at fighting off tumors." The study is the first to target and identify STING, an immune molecule with nanoparticles 1/1 000 000 the size of a soccer ball which has the ability to switch immune activity on or off according to the physiological environment.
To read more about this study, click here.
Study mentioned: Suxin Li, Min Luo, Zhaohui Wang, Qiang Feng, Jonathan Wilhelm, Xu Wang, Wei Li, Jian Wang, Agnieszka Cholka, Yang-xin Fu, Baran D. Sumer, Hongtao Yu, Jinming Gao. Prolonged activation of innate immune pathways by a polyvalent STING agonist. Nature Biomedical Engineering, 2021; DOI: 10.1038/s41551-020-00675-9
No comments:
Post a Comment